CaV3.1 | voltage-dependent, T type, alpha 1G subunit calcium channel

Calcium channels

L-Type (CaV1.1–CaV1.4), P/Q-Type (CaV2.1), N-Type (CaV2.2), R-Type (CaV2.3), T-Type (CaV3.1–CaV3.3)

Six transmembrane alpha helices (S1–S6), total of four homologous domains make up the tetrameric alpha subunit structure

One large alpha subunit forms a functional channel, accessory subunits ( α1, α2δ, β1-4, and γ) are crucial for robust expression, they functionally modulate the alpha subunit

CaV3.1 Background Information


CaV3.1 give rise to the T-type currents: Low-voltage-activated calcium channels are referred to as 'T' type because their currents are both transient, owing to fast inactivation, and tiny, owing to small conductance. T-type channels are thought to be involved in pacemaker activity, low-threshold calcium spikes, neuronal oscillations and resonance, and rebound burst firing. CaV3.1 channels are found in neurons and cardiac tissue. It serves pacemaking functions in both central neurons and cardiac nodal cells and supports calcium signaling in secretory cells and vascular smooth muscle. Its involvement in the modulation of firing patterns of neurons is important for information processing as well as in cell growth processes. The potentiation of CaV3.1 T-type Ca2+ channels in the inferior olive contributes to the onset of the tremor in a pharmacological model of essential tremor.

Data Sheet:


Human Protein:
UniProt O43497

brain neurons, cardiac nodal cells, smooth muscle cells

Function/ Application:
Ca2+pacemaker function, support calcium signalling in secretory cells and smooth muscle cells

Spinocerebellar ataxia 42, colorectal cancer, central pain syndrome, childhood absence epilepsy, osteogenesis imperfecta type i

β1-4 subunits, α2δ subunits, insulin, CaCNG3, Ras protein-specific guanine nucleotide-releasing factor 2, CaV1.2, Calsequestrin 2, TRPC5

Mibefradil, verapamil, zonisame, flunarizide, Bay K 8644, Nitrendipine

Patch Clamp: whole cell, room temperature

CaV channels often show a rundown phenomenon. Adequate intra- and extracellular solutions are essential for a good data quality.

Reviews and Links


2022 - Discovery of novel activators of large-conductance calcium-activated potassium channels for the treatment of cerebellar ataxia

icon sp96 SyncroPatch 384PE (a predecessor model of the SyncroPatch 384 instrument) publication in Molecular Pharmacology (2022)

Srinivasan S.R.Huang H.Chang W.C.Nasburg J.A.Nguyen H.M.Strassmaier T.Wulff H., Shakkottai V.G.

2018 - Mechanism-specific assay design facilitates the discovery of Nav1.7-selective inhibitors

icon sp96  SyncroPatch 768PE (a predecessor model of the SyncroPatch 384/768i) publication in PNAS

Chernov-Rogan T., Li T., Lu G., Verschoof H., Khakh K., Jones S.W., Beresini M.H., Liu C., Ortwine D.F., McKerrall S.J., Hackos D.H., Sutherlin D., Cohen C.J., and Chen J.

2011 - Pharmacological studies of Cav3.1 T-type calcium channels using automated patch-clamp techniques

icon pl  Patchliner publication in General Physiology and Biophysics (2011)

Choi K.-H., Song C., Cheong C.S., Rhim H.

2009 - T-type channel blocking properties and antiabsence activity of two imidazo[1,2-b]pyridazine derivatives structurally related to indomethacin

icon pap  Port-a-Patch publication in Neuropharmacology (2009)

Rimoli M.G., Russo E., Cataldi M., Citraro R., Ambrosino P., Melisi D., Curcio A., De Lucia S., Patrignani P., De Sarro G., Abignente E.

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.